News
- Author:
- Jake Remaly
Publish date: December 17, 2019
The agency also authorized the first newborn screening test for DMD.
News
- Author:
- Jake Remaly
Publish date: December 11, 2019
BALTIMORE – A secondary diagnosis of apnea is not independently associated with increased odds of death, however.
News
- Author:
- Jake Remaly
Publish date: December 10, 2019
BALTIMORE – Presentations often differ subtly from the prototypical phenotype.
News
- Author:
- Jake Remaly
Publish date: December 9, 2019
BALTIMORE – The effect of caffeine on seizures may be dose dependent, with moderate doses potentially benefiting patients with epilepsy and high do...
News
- Author:
- Jake Remaly
Publish date: December 8, 2019
About 19% of confirmed seizure clusters in EpiDiary entries may be found only through free-text notes.
News
- Author:
- Jake Remaly
Publish date: December 4, 2019
Two hours after treatment, the investigational acute migraine therapy results in higher rates of pain freedom and freedom from photophobia, phonoph...
News
- Author:
- Jake Remaly
Publish date: November 27, 2019
Randomized study of fosphenytoin, valproate, and levetiracetam informs management of benzodiazepine-refractory disease.
News
- Author:
- Jake Remaly
Publish date: November 27, 2019
During a trial of the recently approved drug, investigators lowered the starting dose and slowed the rate of up-titration to address a risk of hype...
News
- Author:
- Jake Remaly
Publish date: November 19, 2019
More patients who received the oral CGRP receptor antagonist were free of pain 2 hours later, compared with patients who received placebo, accordin...
News
- Author:
- Jake Remaly
Publish date: November 6, 2019
A positive dose-response relationship exists between the number of insomnia symptoms and the risk of cardiocerebral vascular disease, according to ...
News
- Author:
- Jake Remaly
Publish date: November 5, 2019
LAS VEGAS – Insufficient dosing of urate lowering therapy may be a reason for perceived treatment resistance.
News
- Author:
- Jake Remaly
Publish date: October 30, 2019
The oral drug, marketed as Vumerity, converts to the same active metabolite as dimethyl fumarate.
News
- Author:
- Jake Remaly
Publish date: October 29, 2019
AUSTIN, TEX. – Testing for binding antibodies and for modulating antibodies may be more accurate than testing for either subtype alone.
News
- Author:
- Jake Remaly
Publish date: October 28, 2019
CHARLOTTE, N.C. – Functional measures and disease biomarkers stabilized when patients received the investigational NF-kB inhibitor.
News
- Author:
- Jake Remaly
Publish date: October 28, 2019
CHARLOTTE, N.C. – A compassionate use trial indicates that JAK inhibition may have a role in the treatment of genetic interferonopathies.
